How neuropsychiatric comorbidity, modulatory indication, demographics, and other factors impact deep brain stimulation inpatient outcomes in the United States: A population-based study of 27,956 patients

Kortz, Michael W.; Kongs, Brian M; McCray, Edwin; Grassia, Fabio; Hosokawa, Patrick; Bernstein, Jacob; Moore, Sean P.; Yanovskaya, Mariya; Ojemann, Steven G.

doi:10.1016/j.clineuro.2021.106842

Cited by 2 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Statements about cultural, ethnic, and racial disparities add to what is known about the historical and ongoing injustices that Indigenous peoples face in the Canadian health care system and the need for culturally safe care, 24,25 and relate to evidence from other countries such as the United States from which racial disparities to DBS and epilepsy surgery have been reported. [26][27][28][29][30][31][32] Limitations Twenty of the experts had little to no direct experience working in rural and remote communities. Their views are expert but can be taken as hypothetical and anticipatory only.…”

Section: Discussionmentioning

confidence: 99%

Mapping the Landscape of Equitable Access to Advanced Neurotechnologies in Canada

Harding

McFarlane

Honey

et al. 2023

Can. J. Neurol. Sci.

View full text Add to dashboard Cite

ABSTRACT:Geographic, social, political, and economic factors shape access to advanced neurotechnologies, yet little previous research has explored the barriers, enablers, and areas of opportunity for equitable and meaningful access for diverse patient communities across Canada. We applied a mixed-mode approach involving semi-structured interviews and rating scale questions to consult with 24 medical experts who are involved in the care of patients who undergo functional neurosurgery targeting the brain. Seven major themes emerged from the qualitative analysis: Health care system, Neurotechnology features, Patient demographics, Target condition features, Ethics, Upstream barriers and enablers, and Areas of opportunity. Descriptive statistics of the Likert-scale responses suggest that interviewees perceive a disparity between the imperative of access to advanced neurotechnologies for people living in rural and remote areas and the likelihood of achieving such access. The results depict a complex picture of access to functional neurosurgery in Canada with pockets of excellence and a motivation to improve the availability of care for vulnerable populations through the expansion of distributed care models, improved health care system efficiencies, increasing funding and support for patient travel, and increasing awareness about and advocacy for advanced neurotechnologies.

show abstract

Section: Discussionmentioning

confidence: 99%

Mapping the Landscape of Equitable Access to Advanced Neurotechnologies in Canada

Harding

McFarlane

Honey

et al. 2023

Can. J. Neurol. Sci.

View full text Add to dashboard Cite

show abstract

“…However, this was a small study (N = 27) specifically analyzing complications in a population of surgical patients that were 75 or older from a single institution. Three other large-scale retrospective chart reviews analyzing data from multiple institutions (populations of 2,228-32,988 patients following DBS for PD, with additional populations of either DBS for other disorders or patients with PD not receiving DBS for comparison) discussed long-term complication rates, which varied from 1.02 to 4.5%, and in-patient mortality rates of 0.17-0.2% (Sharma et al, 2013;Deng et al, 2020;Kortz et al, 2021). All of these studies indicate a relatively small, but certainly not insignificant, rate of complications following DBS and highlight a need for further research into the causes and potential methods of reduction to improve hospitalized patients' outcomes and care following an adverse event.…”

Section: Long-term Outcomes Of Dbsmentioning

confidence: 99%

Deep brain stimulation in PD: risk of complications, morbidity, and hospitalizations: a systematic review

Olson,

Shill,

Ponce

et al. 2023

Front. Aging Neurosci.

View full text Add to dashboard Cite

IntroductionParkinson’s disease (PD) is a progressive and debilitating neurological disorder. While dopaminergic medication improves PD symptoms, continued management is complicated by continued symptom progression, increasing medication fluctuations, and medication-related dyskinesia. Deep brain stimulation (DBS) surgery is a well-accepted and widespread treatment often utilized to address these symptoms in advanced PD. However, DBS may also lead to complications requiring hospitalization. In addition, patients with PD and DBS may have specialized care needs during hospitalization.MethodsThis systematic review seeks to characterize the complications and risk of hospitalization following DBS surgery. Patient risk factors and modifications to DBS surgical techniques that may affect surgical risk are also discussed.ResultsIt is found that, when candidates are carefully screened, DBS is a relatively low-risk procedure, but rate of hospitalization is somewhat increased for DBS patients.DiscussionMore research is needed to determine the relative influence of more advanced disease vs. DBS itself in increased rate of hospitalization, but education about DBS and PD is important to insure effective patient care within the hospital.

show abstract

How neuropsychiatric comorbidity, modulatory indication, demographics, and other factors impact deep brain stimulation inpatient outcomes in the United States: A population-based study of 27,956 patients

Cited by 2 publications

References 33 publications

Mapping the Landscape of Equitable Access to Advanced Neurotechnologies in Canada

Mapping the Landscape of Equitable Access to Advanced Neurotechnologies in Canada

Deep brain stimulation in PD: risk of complications, morbidity, and hospitalizations: a systematic review

Contact Info

Product

Resources

About